Corilagin对小鼠小胶质细胞株照射后炎性反应因子表达的抑制作用

目的 研究抗炎药物Corilagin抑制放射引起小胶质细胞(BV-2)炎性反应的作用及其防护的分子机制。方法 细胞抑制实验(MTT)检测Corilagin对BV-2细胞的抑制率;Corilagin预处理小胶质细胞,12 h后,以0和32 Gy 2个放射剂量照射BV-2细胞,Real-time PCR检测小胶质细胞照射后不同时间点炎性反应因子IL-1β、TNF-α表达水平;硝酸还原酶法检测细胞上清液中一氧化氮(NO)的含量;Western blot检测各组细胞核转录因子NF-κB p65蛋白表达;激光共聚焦显微镜观察各组细胞标志物Iba-1的表达、NF-κB p65核转位及Nemo的表达。结果 1～10 μg/ml浓度范围内Corilagin对BV-2细胞增殖几乎无影响;照射后小胶质细胞表面标志物Iba-1表达明显,提示小胶质细胞激活,且炎性反应因子NO、TNF-α、IL-1β表达上调,而Corilagin(5μg/ml)可以显著抑制上述炎性反应因子的表达(t_IL-1β=6.341, t_TNF-α=3.411, t_NO=3.134, P <0.05);Corilagin可抑制NF-κB活化蛋白Nemo,并显著抑制NF-κB p65的转位。结论 Corilagin可能通过NF-κB信号转导途径抑制照射后小胶质细胞的活化,从而下调炎性反应因子表达,保护神经元。

Inhibitory effect of Corilagin on the inflammatory response of irradiated microglia BV-2 cells

Objective To explore the inhibitory effects of Corilagin on the production of proinflammatory cytokines in microglia induced by radiation. Methods The cytotoxicity of Corilagin was measured by MTT assay. Microglia BV-2 cells were irradiated 0 or 32 Gy after pretreated with Corilagin for 12 hours. Realtime-PCR was used to detect the mRNA levels of inflammatory cytokines, such as IL-1β,TNF-α on several time-points. The content of nitric oxide (NO) was determined with nitrate reductase method. The translocation of NF-κB was measured by Western blot and immunocytochemical stain.Confocal microscopy was used to observe the expression of Iba-1 and Nemo. Results No cytotoxicity was detected on BV-2 cells with 1-10 μg/ml Corilagin. Iba-1 expression in microglia cells was activated by irradiation, the expression levels of inflammatory cytokines, such as IL-1β, TNF-α and NO were also elevated. Whereas, the production of IL-1 β, TNF-α in activated microglia cells was significantly inhibited with 5 μg/mL corilagin ( tIL-1β = 6. 341, tTNF-α = 3.41 1, tNO = 3. 134, P ＜ 0. 05 ). Corilagin significantly inhibited the expression of Nemo and the translocation of NF-κB p65. Conclusion Corilagin could inhibit the activation of irradiated microglia cells and down-regulate the expression of inflammatory cytokines, via inhibition of the NF-κB signaling pathway.